Paper33925005
Simultaneous Use of ROCK Inhibitors and EP2 Agonists Induces Unexpected Effects on Adipogenesis and the Physical Properties of 3T3-L1 Preadipocytes.
Ida Y and 3 others. Int J Mol Sci, 2021. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Simultaneous Use of ROCK Inhibitors and EP2 Agonists Induces Unexpected Effects on Adipogenesis and the Physical Properties of 3T3-L1 Preadipocytes. Papers, record 33925005. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33925005
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Simultaneous Use of ROCK Inhibitors and EP2 Agonists Induces Unexpected Effects on Adipogenesis and the Physical Properties of 3T3-L1 Preadipocytes.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adipogenesis | Major topic |
| Alprostadil | Major topic |
| Glycine | Major topic |
| Isoquinolines | Major topic |
| Pyrazoles | Major topic |
| Pyridines | Major topic |
| Sulfonamides | Major topic |
| rho-Associated Kinases | Major topic |
| 3T3-L1 Cells | |
| Animals | |
| Drug Evaluation, Preclinical | |
| Drug Interactions | |
| Mice | |
| Organoids | |
| Receptors, Prostaglandin E, EP2 Subtype |
Source PubMed
References44
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11459852 | PPARgamma : a nuclear regulator of metabolism, differentiation, and cell growth. | J Biol Chem | 2001 | https://conductscience.org/library/papers/11459852 | PubMed |
| 2 | 29410516 | Anti-adipogenic effects of KD025 (SLx-2119), a ROCK2-specific inhibitor, in 3T3-L1 cells. | Sci Rep | 2018 | https://conductscience.org/library/papers/29410516 | PubMed |
| 3 | 8309950 | Prostanoid receptors and their biological actions. | Prog Lipid Res | 1993 | https://conductscience.org/library/papers/8309950 | PubMed |
| 4 | 7493923 | A novel serine/threonine kinase binding the Ras-related RhoA GTPase which translocates the kinase to peripheral membranes. | J Biol Chem | 1995 | https://conductscience.org/library/papers/7493923 | PubMed |
| 5 | 8536636 | Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. | Endocrinology | 1996 | https://conductscience.org/library/papers/8536636 | PubMed |
| 6 | 23650502 | A cross-sectional survey of the association between bilateral topical prostaglandin analogue use and ocular adnexal features. | PLoS One | 2013 | https://conductscience.org/library/papers/23650502 | PubMed |
| 7 | 11353805 | Key structural features of prostaglandin E(2) and prostanoid analogs involved in binding and activation of the human EP(1) prostanoid receptor. | Mol Pharmacol | 2001 | https://conductscience.org/library/papers/11353805 | PubMed |
| 8 | 22355071 | Regulation of glucose transport by ROCK1 differs from that of ROCK2 and is controlled by actin polymerization. | Endocrinology | 2012 | https://conductscience.org/library/papers/22355071 | PubMed |
| 9 | 29677370 | Topical Ripasudil Suppresses Retinal Ganglion Cell Death in a Mouse Model of Normal Tension Glaucoma. | Invest Ophthalmol Vis Sci | 2018 | https://conductscience.org/library/papers/29677370 | PubMed |
| 10 | 32533949 | Omidenepag Isopropyl Versus Latanoprost in Primary Open-Angle Glaucoma and Ocular Hypertension: The Phase 3 AYAME Study. | Am J Ophthalmol | 2020 | https://conductscience.org/library/papers/32533949 | PubMed |
| 11 | 32994409 | Omidenepag, a non-prostanoid EP2 receptor agonist, induces enlargement of the 3D organoid of 3T3-L1 cells. | Sci Rep | 2020 | https://conductscience.org/library/papers/32994409 | PubMed |
| 12 | 10508233 | Prostanoid receptors: structures, properties, and functions. | Physiol Rev | 1999 | https://conductscience.org/library/papers/10508233 | PubMed |
| 13 | 19723556 | Adipose tissue as an endocrine organ. | Mol Cell Endocrinol | 2010 | https://conductscience.org/library/papers/19723556 | PubMed |
| 14 | 29102264 | Radiation toxicity in patients with collagen vascular disease and intrathoracic malignancy treated with modern radiation techniques. | Radiother Oncol | 2017 | https://conductscience.org/library/papers/29102264 | PubMed |
| 15 | 17681946 | Genetic and pharmacological inhibition of Rho-associated kinase II enhances adipogenesis. | J Biol Chem | 2007 | https://conductscience.org/library/papers/17681946 | PubMed |
| 16 | 12778124 | Rocks: multifunctional kinases in cell behaviour. | Nat Rev Mol Cell Biol | 2003 | https://conductscience.org/library/papers/12778124 | PubMed |
| 17 | 32409724 | Prostaglandin F2α agonist-induced suppression of 3T3-L1 cell adipogenesis affects spatial formation of extra-cellular matrix. | Sci Rep | 2020 | https://conductscience.org/library/papers/32409724 | PubMed |
| 18 | 29989843 | Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, on Aqueous Humor Dynamics in Laser-Induced Ocular Hypertensive Monkeys. | J Ocul Pharmacol Ther | 2018 | https://conductscience.org/library/papers/29989843 | PubMed |
| 19 | 25076859 | Characteristic expression of extracellular matrix in subcutaneous adipose tissue development and adipogenesis; comparison with visceral adipose tissue. | Int J Biol Sci | 2014 | https://conductscience.org/library/papers/25076859 | PubMed |
| 20 | 31934812 | Effects of the Selective EP2 Receptor Agonist Omidenepag on Adipocyte Differentiation in 3T3-L1 Cells. | J Ocul Pharmacol Ther | 2020 | https://conductscience.org/library/papers/31934812 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39329734 | Application of Single Cell Type-Derived Spheroids Generated by Using a Hanging Drop Culture Technique in Various In Vitro Disease Models: A Narrow Review. | Cells | 2024 | https://conductscience.org/library/papers/39329734 | PubMed |
| 37966572 | Unraveling the rationale and conducting a comprehensive assessment of KD025 (Belumosudil) as a candidate drug for inhibiting adipogenic differentiation-a systematic review. | Naunyn Schmiedebergs Arch Pharmacol | 2024 | https://conductscience.org/library/papers/37966572 | PubMed |
| 36674625 | Unexpected Crosslinking Effects of a Human Thyroid Stimulating Monoclonal Autoantibody, M22, with IGF1 on Adipogenesis in 3T3L-1 Cells. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36674625 | PubMed |
| 36163231 | FGF-2 enhances fibrogenetic changes in TGF-β2 treated human conjunctival fibroblasts. | Sci Rep | 2022 | https://conductscience.org/library/papers/36163231 | PubMed |
| 35523828 | ROCK 1 and 2 affect the spatial architecture of 3D spheroids derived from human corneal stromal fibroblasts in different manners. | Sci Rep | 2022 | https://conductscience.org/library/papers/35523828 | PubMed |
| 35053416 | STAT3 Is the Master Regulator for the Forming of 3D Spheroids of 3T3-L1 Preadipocytes. | Cells | 2022 | https://conductscience.org/library/papers/35053416 | PubMed |
| 34831419 | Reactivities of a Prostanoid EP2 Agonist, Omidenepag, Are Useful for Distinguishing between 3D Spheroids of Human Orbital Fibroblasts without or with Graves' Orbitopathy. | Cells | 2021 | https://conductscience.org/library/papers/34831419 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| PTGER3 | 5733 | PubTator's text mining | https://conductscience.org/library/genes/5733 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33925005
GET https://conductscience.org/api/papers/v1/33925005/references?page=2